Liraglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and support chronic weight management by stimulating glucose-dependent insulin secretion and suppressing… Read more





![Chemical structure of [4-31]-Liraglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2376305-58-5-4-31-Liraglutide.png&w=3840&q=75)
![Chemical structure of [7-31]-Liraglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F7-31-Liraglutide.png&w=3840&q=75)
![Chemical structure of [Trp(O)]25-Liraglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FTrpO25-Liraglutide.png&w=3840&q=75)
![Chemical structure of D-[Phe] 22-Liraglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FD-Phe-22-Liraglutide.png&w=3840&q=75)















![Chemical structure of Des-[Ser]8 Liraglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FDes-Ser8-Liraglutide.png&w=3840&q=75)












![Chemical structure of Fragment-[10-31]-Liraglutide](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FFragment-10-31-Liraglutide.png&w=3840&q=75)










![Chemical structure of Liraglutide Impurity 1 ([Trp(O)]25-Liraglutide)](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FLiraglutide-Impurity-1-TrpO25-Liraglutide.png&w=3840&q=75)

Liraglutide is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and support chronic weight management by stimulating glucose-dependent insulin secretion and suppressing appetite. This category provides essential reference standards, including the active pharmaceutical ingredient, related metabolites, and various degradation products, such as hydrolysis fragments and deamidated forms, which are critical for robust impurity profiling during pharmaceutical development. Laboratories rely on these high-quality compounds, including stable isotope labelled variants, to perform precise quantification, method validation, and routine quality control assays. By utilizing these materials, researchers can effectively identify and monitor impurities, ensuring the accuracy of analytical results and adherence to rigorous safety standards for this therapeutic peptide in accordance with regulatory requirements.